FDA ok's once-daily Kaletra for treatment-experienced HIV patients

The US FDA has approved once-daily dosing of Abbott's fixed-dose combination HIV antiretroviral drug Kaletra (lopinavir/ritonavir (Abbott's Norvir)) for use in treatment-experienced adult patients in combination with other antiretroviral products.